ICR Westwicke

What ICR Westwicke does

ICR Westwicke is the healthcare-focused communications and capital markets advisory division of ICR Inc., a privately held independent US agency. The firm delivers four integrated service modules — Investor Relations, Corporate Communications & Public Relations, IPO & Transaction Advisory, and Branding + Creative — to 200+ healthcare clients across more than 20 countries through a team of 100+ advisors in New York, London, and Beijing. The platform is organized around six healthcare sub-sectors: biotech, medtech, healthcare services, pharmaceuticals, diagnostics & tools, and healthcare information technology (HCIT). The business was built through the acquisition of Westwicke, the largest US healthcare IR agency, and Consilium Strategic Communications, a leading UK healthcare PR firm, both of which continue to operate as retained brands under the ICR Healthcare umbrella. The team was founded by former Wall Street professionals and serves both pre-IPO and public-company clients at every growth stage, translating complex clinical and scientific narratives for investors, media, and other stakeholders.

The underlying product is a relationship-based, human-delivered advisory service rather than a software platform. Service delivery is quote-based and custom-scoped per engagement, with no publicly disclosed pricing. ICR Healthcare generates revenue through professional services retainers and project-based fees across its four service lines. Notable client logos span large-cap healthcare names (Abbott, Agilent, Teleflex) and growth-stage biotech/digital health issuers (OMass Therapeutics, Replimune, Talkspace, Compass Pathways, Moonlake, Gracell). The firm is privately held under the parent entity ICR Inc. and reports no evidence of outside private equity or venture capital ownership. The broader parent agency extends across 10+ additional industry verticals (technology, consumer, financial services, energy, crypto, etc.), providing cross-sector infrastructure, although the healthcare unit is the primary subject of this analysis.

Name

ICR Westwicke

Legal name

ICR Inc.

Website

https://westwicke.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

ICR Westwicke is the healthcare-focused arm of ICR Inc., delivering integrated investor relations, corporate communications, IPO advisory, and branding services to 200+ healthcare companies across biotech, medtech, pharma, diagnostics, HCIT, and healthcare services globally.

Ownership category

akta.pro rank

Product category

Healthcare Communications & Investor Relations Advisory

NAICS

Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523), Management, Scientific, and Technical Consulting Services (5416), Management Consulting Services (54161)

SIC

Security Brokers, Dealers & Flotation Companies (6211), Investment Advice (6282)

akta.pro primary industry

Capital Markets Advisory (IPO Readiness, SPAC, ECM/DCM Advisory) (BPAHAOAL)

akta.pro secondary industries

Corporate Development & Strategic Partnerships Advisory (JVs, Alliances, Carve-outs) (BPAHAOAG), Fairness Opinions & Independent Financial Advice (BPAHAOAF)

Keywords

• Investor relations advisory
• Healthcare communications
• IPO advisory services
• Capital markets advisory
• Corporate communications

Headquarters

HQ city

Baltimore

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Professional Advisory Services: Revenue generated from providing strategic communications, investor relations, corporate communications, IPO advisory, and branding/creative services to healthcare companies

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

ICR Westwicke provides customized investor relations programs and independent capital markets advice to healthcare companies. The firm delivers strategic communications, corporate communications and PR, IPO and transaction advisory, and branding/creative services to healthcare innovators across biotech, pharma, medtech, diagnostics, healthcare services and HCIT sectors, supported by a team of 100+ advisors across the US, Europe and Asia serving 200+ clients in 20+ countries.

Product overview

ICR Healthcare operates as a comprehensive strategic healthcare communications platform offering four integrated service modules: Investor Relations, Corporate Communications & Public Relations, IPO & Transaction Advisory, and Branding + Creative. These services work together to provide seamless communications and advisory support across the healthcare sector, combining niche sector expertise with the resources of one of the largest independent US agencies. The company serves 200+ clients across 20+ countries through a team of 100+ advisors in the US, Europe, and Asia.

Differentiator

Problem solved

Functional benefit

Brands

• Westwicke: Healthcare investor relations brand operating under ICR, described as the largest healthcare investor relations agency in the US

Products and services

• Investor Relations

Quantifiable outcome

• Supporting 200+ clients in 20+ countries
• +1 more outcomes

Named customers25 records

Segments6 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• WestwickecoreStrategic or Co-development PartnerWestwicke was acquired by ICR and is described as the largest healthcare investor relations agency in the US. This acquisition expanded ICR's healthcare communications capabilities and established the foundation for the ICR Healthcare team.
• Consilium Strategic CommunicationscoreStrategic or Co-development PartnerConsilium Strategic Communications was acquired by ICR. It is a leading healthcare PR firm headquartered in the UK. The acquisition provided ICR with European healthcare communications expertise and expanded their global reach.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Brunswick Group: Brunswick is a global advisory firm specialising in critical financial and corporate communications. It serves healthcare companies on IPO readiness, M&A and crisis communications, overlapping with ICR Westwicke's investor relations and capital markets advisory work but across broader sectors.
• Edelman (Health Practice): Edelman is one of the largest global PR firms with a dedicated Health practice serving pharmaceutical, biotech and consumer health clients. It overlaps with ICR Westwicke on healthcare corporate communications and brand work but offers that capability as part of a far broader, multi-sector portfolio.
• FTI Consulting (Strategic Communications): FTI Consulting's Strategic Communications segment provides corporate reputation, capital markets advisory and public affairs work, including a healthcare practice. It overlaps with ICR Westwicke on healthcare IPO advisory and capital markets positioning but as part of a much broader advisory platform.
• FleishmanHillard (Healthcare Practice): FleishmanHillard is a global PR and integrated communications network with a sizeable healthcare and life sciences practice. It competes with ICR Westwicke for healthcare PR and corporate communications mandates but serves many other industries and is not health-exclusive.

Direct peers

• Finn Partners: Finn Partners operates a large Health practice and is a frequent competitor for biotech and health-tech public relations, patient advocacy and corporate communications engagements. Its integrated health-and-technology offering closely parallels ICR Westwicke's four-module service stack.
• Real Chemistry: Real Chemistry (formerly W2O Group) is a healthcare-focused marketing, communications and data science firm serving biotech, pharma and consumer health clients. It directly competes with ICR Westwicke for healthcare communications, investor relations and brand engagements, with comparable sub-sector specialisation.
• Havas Health & You: Havas Health & You is a global health-and-wellness communications network serving pharma, biotech, OTC and consumer health clients. It competes head-to-head with ICR Westwicke on integrated healthcare PR, corporate communications and creative engagements for similar enterprise healthcare buyers.
• LifeSci Communications: LifeSci Communications is a specialty communications and investor relations firm focused exclusively on life sciences and biotech clients. Its vertical specialisation, IR-led offering and biotech client roster mirror ICR Westwicke's positioning in the same healthcare communications category.
• Stern Investor Relations: Stern IR is a US IR advisory firm focused on small- and mid-cap companies, including a meaningful healthcare and life sciences practice. It is a direct competitor for healthcare investor relations mandates where ICR Westwicke's Westwicke arm is also commonly engaged.

Emerging players

• Canale Communications: Canale Communications is a healthcare-dedicated communications and investor relations boutique serving biotech and medtech clients. It is smaller than ICR Westwicke but competes directly for biotech IR and corporate communications engagements with comparable specialisation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/westwickeIR
• LinkedInlinkedin.com/company/westwicke
• Instagraminstagram.com/icrincllc
• Facebookfacebook.com/Westwicke

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ICR Westwicke